SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 86 filers reported holding SEELOS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $51,948 | -86.1% | 282,327 | -9.6% | 0.00% | -100.0% |
| Q2 2023 | $373,308 | +67.0% | 312,392 | -3.4% | 0.00% | 0.0% |
| Q1 2023 | $223,483 | -74.4% | 323,326 | -74.9% | 0.00% | -50.0% |
| Q4 2022 | $874,001 | -60.8% | 1,287,189 | -40.5% | 0.00% | -50.0% |
| Q3 2022 | $2,227,000 | +41.0% | 2,161,965 | -6.8% | 0.00% | +100.0% |
| Q2 2022 | $1,579,000 | -15.9% | 2,320,946 | +3.6% | 0.00% | 0.0% |
| Q1 2022 | $1,878,000 | +18.8% | 2,241,068 | +131.0% | 0.00% | +100.0% |
| Q4 2021 | $1,581,000 | +2008.0% | 969,993 | +3305.0% | 0.00% | – |
| Q2 2021 | $75,000 | – | 28,487 | +167470.6% | 0.00% | – |
| Q4 2020 | $0 | – | 17 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 17 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 17 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 17 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 17 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 17 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 17 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 17 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Uniplan Investment Counsel, Inc. | 2,033,020 | $1,904,000 | 0.13% |
| 1492 Capital Management LLC | 150,000 | $141,000 | 0.11% |
| Spark Investment Management LLC | 13,100 | $12,000 | 0.02% |
| ARDSLEY ADVISORY PARTNERS LP | 80,000 | $75,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 27,437 | $26,000 | 0.00% |
| WealthPLAN Partners, LLC | 20,000 | $18,000 | 0.00% |
| CIBC WORLD MARKET INC. | 500,000 | $468,000 | 0.00% |
| CAPITAL COUNSEL LLC/NY | 10,000 | $9,000 | 0.00% |
| J.W. COLE ADVISORS, INC. | 10,000 | $9,000 | 0.00% |
| Renaissance Technologies | 591,086 | $554,000 | 0.00% |